| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5891868 | BAYER HLTHCARE | Methods for treating postmenopausal women using ultra-low doses of estrogen |
Nov, 2017
(6 years ago) | |
| US6692763 | BAYER HLTHCARE | Methods for treating postmenopausal women using ultra-low doses of estrogen |
Nov, 2017
(6 years ago) | |
Menostar is owned by Bayer Hlthcare.
Menostar contains Estradiol.
Menostar has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Menostar are:
- US5891868
- US6692763
Menostar was authorised for market use on 08 June, 2004.
Menostar is available in system;transdermal dosage forms.
Menostar can be used as prevention of postmenopausal osteoporosis.
The generics of Menostar are possible to be released after 21 November, 2017.
Drugs and Companies using ESTRADIOL ingredient
Market Authorisation Date: 08 June, 2004
Treatment: Prevention of postmenopausal osteoporosis
Dosage: SYSTEM;TRANSDERMAL
More Information on Dosage
MENOSTAR family patents
